000 | 01462 a2200397 4500 | ||
---|---|---|---|
005 | 20250514051119.0 | ||
264 | 0 | _c20021213 | |
008 | 200212s 0 0 eng d | ||
022 | _a1351-0711 | ||
024 | 7 |
_a10.1136/oem.59.11.785 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVandenplas, O | |
245 | 0 | 0 |
_aFever and neutrophilic alveolitis caused by a vanadium based catalyst. _h[electronic resource] |
260 |
_bOccupational and environmental medicine _cNov 2002 |
||
300 |
_a785-7 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlbuterol _xtherapeutic use |
650 | 0 | 4 |
_aAlveolitis, Extrinsic Allergic _xchemically induced |
650 | 0 | 4 |
_aBronchodilator Agents _xtherapeutic use |
650 | 0 | 4 | _aDust |
650 | 0 | 4 |
_aFever _xchemically induced |
650 | 0 | 4 |
_aForced Expiratory Flow Rates _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOccupational Diseases _xchemically induced |
650 | 0 | 4 |
_aOccupational Exposure _xadverse effects |
650 | 0 | 4 |
_aVanadium Compounds _xadverse effects |
650 | 0 | 4 |
_aVital Capacity _xdrug effects |
700 | 1 | _aBinard-Van Cangh, F | |
700 | 1 | _aGregoire, J | |
700 | 1 | _aBrumagne, A | |
700 | 1 | _aLarbanois, A | |
773 | 0 |
_tOccupational and environmental medicine _gvol. 59 _gno. 11 _gp. 785-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/oem.59.11.785 _zAvailable from publisher's website |
999 |
_c12217737 _d12217737 |